| Ident. | Authors (with country if any) | Title |
|---|
| 000166 (2012) |
Peng Wang [États-Unis] ; Anthony Lutton [États-Unis] ; John Olesik [États-Unis] ; Hojatollah Vali [Canada] ; Xin Li [États-Unis] | A novel iron‐ and copper‐binding protein in the Lyme disease spirochaete |
| 000229 (2012) |
Fred W. J Ger [Allemagne] ; Fred W. Bats [Allemagne] ; Fred W. Ihmels [Allemagne] ; Fred W. Granzhan [Allemagne, France] ; Sandra Uebach [Allemagne] ; Sandra Patrick [Canada] | Polycyclic Azoniahetarenes: Assessing the Binding Parameters of Complexes between Unsubstituted Ligands and G‐Quadruplex DNA |
| 000260 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease |
| 000474 (2011) |
Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
| 000899 (2008) |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys |
| 000900 (2008) |
Carol Anne Chénard [Canada] ; Stéphane Richard [Canada] | New implications for the QUAKING RNA binding protein in human disease |
| 000932 (2008) |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB |
| 000A08 (2007) |
Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada] | Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia |
| 000A86 (2007) |
M. Guttman [Canada] ; I. Boileau [Canada] ; J. Warsh [Canada] ; J. A. Saint-Cyr [Canada] ; N. Ginovart [Canada] ; T. Mccluskey [Canada] ; S. Houle [Canada] ; A. Wilson [Canada] ; E. Mundo [Italie] ; P. Rusjan [Canada] ; J. Meyer [Canada] ; S. J. Kish [Canada] | Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease |
| 000B04 (2006) |
Julie Deschênes-Furry [Canada] ; Nora Perrone-Bizzozero [États-Unis] ; Bernard J. Jasmin [Canada] | The RNA‐binding protein HuD: a regulator of neuronal differentiation, maintenance and plasticity |
| 000E16 (2003) |
Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET |
| 001267 (2000) |
Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo | 125I-CGP 64213 Binding to GABAB Receptors in the Brain of Monkeys: Effect of MPTP and Dopaminomimetic Treatments |
| 001825 (1996) |
J. N. Nobrega [Canada] ; A. Richter [Allemagne] ; N. Tozman [Canada] ; D. Jiwa [Canada] ; W. Loscher [Allemagne] | Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster |
| 001826 (1996) |
Jean-Philippe Charles [États-Unis] ; Hubert Wojtasek [États-Unis] ; Anthony J. Lentz [États-Unis] ; Beth Ann Thomas [États-Unis] ; Bryony C. Bonning [États-Unis] ; Subba Reddy Palli [États-Unis, Canada] ; Anthony G. Parker [États-Unis] ; György Dorman [États-Unis] ; Bruce D. Hammock [États-Unis] ; Glenn D. Prestwich [États-Unis] ; Lynn M. Riddiford [États-Unis] | Purification and reassessment of ligand binding by the recombinant, putative juvenile hormone receptor of the tobacco hornworm, Manduca sexta |
| 001D22 (1993) |
Ananda Prasad Sen [Canada] ; Patricia Boksa [Canada] ; Rémi Quirion [Canada] | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
| 001E05 (1992) |
K. Yashpal [Canada] ; S. Kar [Canada] ; T. Dennis [Canada] ; R. Quirion [Canada] | Quantitative autoradiographic distribution of calcitonin gene‐related peptide (hCGRPα) binding sites in the rat and monkey spinal cord |
| 001F71 (1991) |
S. Clas [Canada] | Increasing the in vitro bile acid binding capacity of diethylaminoethylcellulose by quaternization |
| 001F99 (1991) |
Christine Tousignant [Canada] ; Gaétan Guillemette [Canada] ; Domenico Regoli [Canada] | Binding sites for [3H][Sar9, Met(O2)11]substance P in rat bain and guinea pig ileum |
| 002073 (1990) |
Kiran Yashpal [Canada] ; Than-Vinh Dam [Canada] ; Re Mi Quirion [Canada] | Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord |
| 002193 (1989) |
K. Fuxe [Suède] ; B. Tinner [Italie] ; A. M. Janson [Suède] ; A. Cintra [Suède] ; W. Staines [Italie] ; L. F. Agnati [Suède] | On the cellular localization and distribution of the ganglioside GM1 in the rat brain as revealed by immunofluorescence histochemistry of cholera toxin binding sites |
| 002202 (1989) |
G. L. Y. Chan [Canada] ; J. E. Axelson [Canada] ; J. D. E. Price [Canada] ; K. M. Mcerlane [Canada] ; C. R. Kerr [Canada] | In vitro protein binding of propafenone in normal and uraemic human sera |
